About: Pemtumomab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Pemtumomab (trade name Theragyn) is a mouse monoclonal antibody used to treat cancer. The substance has affinity to various types of cancer, like ovarian cancer and peritoneal cancer, via the polymorphic epithelial mucin (PEM or MUC-1) and delivers the radioisotope Yttrium-90 into the tumour. As of 2009, it is undergoing Phase III clinical trials. It has been granted orphan drug status in Europe.

Property	Value
dbo:abstract	Pemtumomab (trade name Theragyn) is a mouse monoclonal antibody used to treat cancer. The substance has affinity to various types of cancer, like ovarian cancer and peritoneal cancer, via the polymorphic epithelial mucin (PEM or MUC-1) and delivers the radioisotope Yttrium-90 into the tumour. As of 2009, it is undergoing Phase III clinical trials. It has been granted orphan drug status in Europe. (en)
dbo:alternativeName	Theragyn (en)
dbo:casNumber	646032-04-4
dbo:wikiPageID	9402948 (xsd:integer)
dbo:wikiPageLength	2368 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1033001846 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Mouse dbc:Experimental_drugs dbr:Orphan_drug dbr:Monoclonal_antibody dbr:MUC1 dbr:Yttrium-90 dbr:Clinical_trials dbc:Orphan_drugs dbc:Monoclonal_antibodies_for_tumors dbr:Intraperitoneal dbr:Ovarian_cancer dbr:Radioisotope dbr:Polymorphic_epithelial_mucin dbr:Peritoneal_cancer
dbp:atcPrefix	none (en)
dbp:casNumber	646032 (xsd:integer)
dbp:chemspiderid	none (en)
dbp:routesOfAdministration	dbr:Intraperitoneal
dbp:source	o (en)
dbp:target	dbr:MUC1
dbp:tradename	Theragyn (en)
dbp:type	mab (en)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	400279517 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Antineoplastic-drug-stub dbt:As_of dbt:Drugbox dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Monoclonal-antibody-stub dbt:Monoclonals_for_tumors
dcterms:subject	dbc:Experimental_drugs dbc:Orphan_drugs dbc:Monoclonal_antibodies_for_tumors
gold:hypernym	dbr:Antibody
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:MonoclonalAntibody yago:WikicatMonoclonalAntibodiesForTumors yago:Abstraction100002137 yago:Antibody115027189 yago:Chemical114806838 yago:Compound114818238 yago:Macromolecule114944888 yago:Material114580897 yago:Matter100020827 yago:Molecule114682133 yago:MonoclonalAntibody115029781 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Protein114728724 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:Thing100002452 yago:Unit109465459 umbel-rc:DrugProduct
rdfs:comment	Pemtumomab (trade name Theragyn) is a mouse monoclonal antibody used to treat cancer. The substance has affinity to various types of cancer, like ovarian cancer and peritoneal cancer, via the polymorphic epithelial mucin (PEM or MUC-1) and delivers the radioisotope Yttrium-90 into the tumour. As of 2009, it is undergoing Phase III clinical trials. It has been granted orphan drug status in Europe. (en)
rdfs:label	Pemtumomab (en)
owl:sameAs	freebase:Pemtumomab yago-res:Pemtumomab wikidata:Pemtumomab https://global.dbpedia.org/id/4tJ7s
prov:wasDerivedFrom	wikipedia-en:Pemtumomab?oldid=1033001846&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Pemtumomab
is dbo:wikiPageWikiLink of	dbr:List_of_therapeutic_monoclonal_antibodies dbr:List_of_drugs:_Pb–Pe
is foaf:primaryTopic of	wikipedia-en:Pemtumomab